Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids